Literature DB >> 23306965

Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome.

Kazutaka Sugimoto1, Makoto Ideguchi, Hirokazu Sadahiro, Koichi Yoshikawa, Hisaharu Goto, Sadahiro Nomura, Masami Fujii, Michiyasu Suzuki.   

Abstract

We report a case of intracranial yolk sac tumor in a 17-year-old girl with Down syndrome who presented with left slowly progressive hemiparesis. Initial magnetic resonance imaging (MRI) showed a small area of ill-defined abnormal signal intensity without a mass in the bilateral basal ganglia. These findings progressed very slowly for 2 years, but then the lesion rapidly progressed to a huge mass on MRI 4 months after the previous scan. The patient subsequently underwent a blood examination and endoscopic biopsy, and was finally diagnosed with yolk sac tumor. Standard platinum-based chemotherapy and radiotherapy were performed as soon as practicable. The frequency of solid cancer in patients with Down syndrome is generally lower than that in individuals without this disorder. Brain tumor is also rare in Down syndrome, but half of these cases are germ cell tumors. Moreover, slowly progressive non-tumor-like lesions in the basal ganglia may also be germ cell tumors. Therefore, MRI signal abnormalities in the basal ganglia in patients with Down syndrome require careful and frequent follow-up scans based on the possibility of a germ cell tumor that may exhibit rapid growth.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306965     DOI: 10.1007/s10014-012-0134-9

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  4 in total

1.  Brentuximab-vedotin maintenance following chemotherapy without irradiation for primary intracranial embryonal carcinoma in down syndrome.

Authors:  Mohammad H Abu Arja; Suzanne E Conley; Violeta Salceda; Fahd Al-Sufiani; Daniel R Boué; Jonathan L Finlay
Journal:  Childs Nerv Syst       Date:  2017-12-13       Impact factor: 1.475

2.  Multifocal primary intracranial yolk sac tumor in an adult patient: a case report and literature review.

Authors:  Xiaochen Yang; Yubo Wang; Geng Chen; Xinyu Hong
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

Review 3.  Multidisciplinary treatment of primary intracranial yolk sac tumor: A case report and literature review.

Authors:  Zhen-Ning Xu; Xiang-Yong Yue; Xiao-Ci Cao; Ya-Dong Liu; Bao-Shuan Fang; Wen-Hao Zhao; Chen Li; Shuai Xu; Ming Zhang
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

4.  Effect of ketorolac tromethamine combined with dezocine prior administration on hemodynamics and postoperative analgesia in patients undergoing laparoscopic hernia repair.

Authors:  Yu Wu; Zenghua Cai; Yanli Li; Yuling Kang; Bohan Fu; Jinbao Wang
Journal:  Medicine (Baltimore)       Date:  2022-05-20       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.